Rett Syndrome Clinical Trial
— ActivRettOfficial title:
Implementing Telehealth Support to Increase Physical Activity in Girls and Women With Rett Syndrome
This study will recruit families with a daughter with Rett syndrome living in either Australia, Denmark or Israel, and thereafter deliver individually designed participation programs using telehealth strategies. We will evaluate the effectiveness of the programs on reducing sedentary behaviours, increasing physical activity and increasing quality of life.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 1, 2021 |
Est. primary completion date | September 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Genetically confirmed Rett syndrome - Able to stand (with or without assistance) - Live in Australia, Denmark or Israel Exclusion Criteria: - Individuals who have had spinal fusion over the previous 12 months - Individuals who have had lower extremity orthopaedic surgery over the previous 6 months |
Country | Name | City | State |
---|---|---|---|
Denmark | Center for Rett Syndrom, Rigshospitalet | Copenhagen | |
Israel | Ari'el University | Ari'el |
Lead Sponsor | Collaborator |
---|---|
Telethon Kids Institute | Ariel University, Rigshospitalet, Denmark, University of Haifa |
Denmark, Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average daily uptime (%) | Percentage of time spent active (uptime) over total awake time, measured with an ActivPAL | Average over 4 days, data capture at baseline, after 12 weeks and after 24 weeks | |
Primary | Average daily step count | Number of daily steps measured by Stepwatch Activity Monitor | Average over 4 days, data capture at baseline, after 12 weeks and after 24 weeks | |
Secondary | Sleep quality | Sleep Disturbance Scale for Children. | Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks | |
Secondary | Behaviour | Rett Syndrome Behaviour Scale | Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks | |
Secondary | Child Quality of Life | Quality of Life Inventory-Disability (QI-Disability) | Parent caregiver recall over previous month, data capture at baseline, after 12 weeks and after 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04988867 -
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
|
Phase 2/Phase 3 | |
Recruiting |
NCT00069550 -
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
|
Phase 3 | |
Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
Not yet recruiting |
NCT04041713 -
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT04014985 -
Patients With RETT Syndrome
|
N/A | |
Completed |
NCT02705677 -
Biobanking of Rett Syndrome and Related Disorders
|
||
Terminated |
NCT02790034 -
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05932589 -
Neurophysiologic Biomarkers in Rett Syndrome
|
||
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Completed |
NCT04776746 -
Open-Label Extension Study of Trofinetide for Rett Syndrome
|
Phase 3 | |
Completed |
NCT04181723 -
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
|
Phase 3 | |
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT04514549 -
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
|
||
Completed |
NCT02738281 -
Natural History of Rett Syndrome & Related Disorders
|
||
Terminated |
NCT02562820 -
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
|
Phase 1 | |
Completed |
NCT05687214 -
Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
|
N/A | |
Recruiting |
NCT06199700 -
Esketamine for the Treatment of Rett Syndrome
|
Early Phase 1 | |
Completed |
NCT03941444 -
ANAVEX2-73 Study in Patients With Rett Syndrome
|
Phase 3 | |
Recruiting |
NCT06346106 -
The Diagnostic Experience of Male Rett Syndrome
|